Rachael Kay & Ségolène Sarrailh

Biography- Rachael Kay
Rachael Kay is currently a Research Scientist at i2c Pharma services, focused mainly on formulation and development of pressurized metered dose inhaler products. She graduated from Cardiff University with a Biological Sciences Degree and joined i2c in 2019 as a research scientist. Rachael is the lead scientist for the development of i2c’s patented pMDI technology, Respitab. Her main area of research is the development, characterization and optimization of the pMDI technology. She has significant expertise in a range of analytical techniques and is proficient in conducting tests to characterize inhalation products in line with regulatory guidance.

Biography- Ségolène Sarrailh
Ségolène Sarrailh is Laboratory Manager at Aptar Pharma, Le Vaudreuil France. She graduated from ESCOM (Ecole Supérieure de Chimie Organique et Minérale) with an Engineering Degree in Chemistry. She started as a formulation scientist at Capsugel (France) to develop cosmetics and food supplements liquid formulations in capsules. She joined Aptar Pharma (previously Valois Pharm) in 2005 as a formulation scientist for MDIs, and progressively took in charge MDI testing and filling, and DPI formulation and testing. Since 2015 she is in charge of Pulmonary Route laboratory within R&D department, including filling activities (aerosols and powders) and container closure system evaluation for MDIs and DPIs (from formulation to chemical compatibility and aerosol performance with active ingredients).